Atorvastatin and rosuvastatin improve physiological parameters and alleviate immune dysfunction in metabolic disorders.
Biochemical and Biophysical Research Communications（2016）
摘要
This study was designed to characterize the potential therapeutic effects of two statin drugs commonly used to treat dyslipidemia in inflammation-linked metabolic disorders related to type 2 diabetes.
更多查看译文
关键词
Atorvastatin,Rosuvastatin,Type 2 diabetes,Immune restoration,In vivo CTL assay
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要